BRIEF published on 09/30/2025 at 22:20, 4 months 11 days ago Nanobiotix : Bilan financier et avancées cliniques au 1er semestre 2025 Résultats Financiers Biotechnologie NANOBIOTIX Johnson & Johnson JNJ-1900
BRIEF published on 09/30/2025 at 22:20, 4 months 11 days ago Nanobiotix: Financial results and clinical progress in the first half of 2025 Financial Results Biotechnology NANOBIOTIX Johnson & Johnson JNJ-1900
PRESS RELEASE published on 09/30/2025 at 22:15, 4 months 11 days ago NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2025 Nanobiotix fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2025, marqué par le développement clinique de JNJ-1900 et une gestion financière rigoureuse Résultats Financiers Développement Clinique Gestion Financière NANOBIOTIX JNJ-1900
PRESS RELEASE published on 09/30/2025 at 22:15, 4 months 11 days ago NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results Nanobiotix provides business update & reports 2025 half year financial results. Highlights clinical development program & financial performance Financial Results Financial Performance Business Update Clinical Development NANOBIOTIX
BRIEF published on 09/30/2025 at 00:35, 4 months 12 days ago NANOBIOTIX Reports Promising Phase 1 Results for JNJ-1900 (NBTXR3) in R/M-HNSCC Phase 1 Trial NANOBIOTIX Clinical Study Results R/M-HNSCC JNJ-1900 (NBTXR3)
BRIEF published on 09/30/2025 at 00:35, 4 months 12 days ago NANOBIOTIX annonce des résultats prometteurs de phase 1 pour JNJ-1900 (NBTXR3) dans le traitement du carcinome épidermoïde œsophagien (HNSCC) métastatique (R/M) NANOBIOTIX Essai De Phase 1 Résultats Des Études Cliniques R/M-HNSCC JNJ-1900 (NBTXR3)
PRESS RELEASE published on 09/30/2025 at 00:30, 4 months 12 days ago NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC Nanobiotix announces updated phase 1 results supporting JNJ-1900 plus anti-PD-1 as a new option in R/M-HNSCC. Promising local and systemic responses presented at ASTRO 2025 NANOBIOTIX Anti-PD-1 JNJ-1900 R/M-HNSCC ASTRO 2025
BRIEF published on 09/17/2025 at 22:20, 4 months 24 days ago Nouveaux résultats positifs pour NANOBIOTIX dans l'étude de Phase 1 sur le mélanome Efficacité NANOBIOTIX Phase 1 Mélanome JNJ-1900
BRIEF published on 09/17/2025 at 22:20, 4 months 24 days ago New Positive Results for NANOBIOTIX in Phase 1 Melanoma Study Efficiency Melanoma NANOBIOTIX Phase 1 JNJ-1900
Published on 02/12/2026 at 14:30, 12 minutes ago MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/12/2026 at 14:30, 12 minutes ago Loar Holdings Inc. Announces Date and Time for Fourth Quarter and Full Year 2025 Earnings Conference Call
Published on 02/12/2026 at 14:22, 20 minutes ago Worksport Confirms Government Evaluation of Aetherlux(TM) Heat Pump for Potential Long-Term Supply Deal; Certification Accelerated
Published on 02/12/2026 at 14:00, 42 minutes ago Diamond Drilling Confirms Wide Gold Intercept in Northeast Extension of North Pipe at Colosseum
Published on 02/12/2026 at 14:00, 42 minutes ago Kinross to Initiate Two Phase 6,000-8,000 Metre Drill Program on BTU Dixie Halo Property Near Great Bear Property
Published on 02/12/2026 at 14:22, 20 minutes ago tick Trading Software AG: Proposed dividend of EUR 0.85 per share for fiscal year 2024/2025
Published on 02/12/2026 at 13:35, 1 hour 6 minutes ago SMT Scharf AG drives strategic business development forward with targeted measures
Published on 02/12/2026 at 13:35, 1 hour 7 minutes ago ITALY, TRADE SHOWS: KEY 2026, TECHNOLOGIES AND INNOVATIONS FOR CLEAN ENERGY IN RIMINI
Published on 02/12/2026 at 07:30, 7 hours 12 minutes ago Press release - Carrefour announces the sale of Carrefour Romania
Published on 02/12/2026 at 07:30, 7 hours 12 minutes ago Communiqué de presse - Carrefour annonce la cession de Carrefour Roumanie
Published on 02/12/2026 at 07:00, 7 hours 42 minutes ago TERACT - Chiffre d’affaires du 1er semestre 2025-2026
Published on 02/11/2026 at 17:45, 20 hours 57 minutes ago Infotel : Stake held in AeroEx. A publisher of digital compliance and safety solutions for the aerospace industry.